生命科学资讯

Moderna, searching for a rebound, to seek approval of mRNA flu shot

Zenas shares crash after top drug misses expectations in immune disease study

Zenas BioPharma’s Phase 3 autoimmune disease readout disappoints

Citi Maintains 10x Genomics(TXG.US) With Hold Rating - 富途牛牛

Moderna seeks flu vaccine approvals; Neumora Alzheimer's data

Biobeat Technologies drums up $50M for its cuffless blood pressure monitor

Aktis Oncology aims for $209M windfall from 1st biotech IPO of 2026

Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit

Abbott launches AI-based Libre Assist, its new in-app feature for meal planning

MetaVia weighs in with 9% loss as dual agonist enters the obesity ring

Argenx to elevate Massey to CEO as it expands rare disease business

Sanofi doubles down on Earendil in $160M near-term deal

Biggest gainers and losers for Dec. 29, 2025-Jan. 2, 2026

Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)? - Yahoo Finance

14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat

Characterization of RNA interference in the cnidarian Nematostella vectensis reveals partial target silencing but lack of small RNA amplification

The Rho GTPase regulator ARHGEF3 orchestrates hair placode budding by coordinating cell fate and P-cadherin patterning in mice

MMSpa is a deep learning-based tool that enhances the identification of spatial domains in spatial transcriptomics studies

Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms

Modeling of H5N1 influenza virus kinetics during dairy cattle infection suggests the timing of infectiousness